Marksans Pharma Limited, together with its subsidiaries, engages in the research and development, manufacturing, marketing, distribution, and sale of generic pharmaceutical formulations worldwide. The company offers products in the analgesics, benign prostatic hyperplasia, antidiabetic, epilepsy, anti-inflammatory, hyperparathyroidism, diabetes, antacids, neurology, cardiovascular, hormonal, oncology, gastroenterology, antidiabetic, pain management, gynecology, antibiotic, antifungal, antiulceratives, vitamins, dermatology, cephalosporins, injectables, anti-allergy, antibacterial, and hypertension therapeutic areas. It also provides contract research and manufacturing services. Marksans Pharma Limited was incorporated in 1992 and is headquartered in Mumbai, India.

Mr. David  Mohammed

Managing Director of Australia Operations

Mr. Jitendra M. Sharma

Chief Financial Officer

Mr. Varddhman Vikramaditya Jain

Whole-time Director

Mr. Harshavardhan  Panigrahi

Company Secretary, Manager of Legal & Compliance Officer

Mr. Sridhar  Naidu

General Manager of HR & Admin

Mr. Mark B. Saldanha

Non-Independent Executive Chairman, MD & Chief Executive Officer

Mr. Sunil K. Rane

Senior Vice President of QC

Ms. Sandra  Saldanha

Mr. Anjani  Kumar

Chief Operating Officer of Global Operations

Mr. Sathish  Kumar

Managing Director of UK Operations

Nazwa	Kapitalizacja rynkowa
Luye Pharma Group Ltd.	0M
PT Kalbe Farma Tbk.	0M
Virbac SA	0M
Daiichi Sankyo Company, Limited	0M
Astellas Pharma Inc.	0M
NGL Fine-Chem Limited	0M
Bristol-Myers Squibb Company	0M
Orion Oyj	0M
Chugai Pharmaceutical Co., Ltd.	0M
Novartis AG	0M

Marksans Pharma Limited

Marksans Pharma Limited Lista konkurentów

Główni konkurenci